CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Dec. 31, 2012	Dec. 31, 2011
ASSETS
Cash and cash equivalents, $4,499 reserved at December 31, 2012	$ 10,205	$ 13,778
Other current assets	383	758
Total current assets	10,588	14,536
Patent license rights, net	980	0
Furniture and equipment, net	23	160
Total assets	11,591	14,696
LIABILITIES AND EQUITY
Accounts payable	233	77
Accrued compensation	6	13
Other accrued liabilities	55	29
Total current liabilities	294	119
Equity
Common Stock $.0005 par value; 100,000,000 shares authorized; 40,885,411 shares in 2012 and 40,775,411 shares in 2011 issued and outstanding	20	20
Additional paid-in capital	189,181	189,074
Accumulated deficit ($150,335 at December 31, 2012 and $146,755 at December 31, 2011, accumulated during development stage period)	(178,097)	(174,517)
Total Capstone Therapeutics Corp. stockholders' equity	11,104	14,577
Noncontrolling interest	193	0
Total equity	11,297	14,577
Total liabilities and equity	$ 11,591	$ 14,696